Raman Bahal Selected Research

Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)

1/2022

Casimersen for the treatment of Duchenne muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raman Bahal Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 02/2013
4	Lymphoma (Lymphomas) 11/2022 - 02/2015
3	Inborn Genetic Diseases (Disease, Hereditary) 11/2022 - 04/2015
2	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 09/2023 - 01/2022
2	Primary Hyperoxaluria (Oxaluria, Primary) 09/2023 - 11/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 01/2022
2	Splenomegaly 01/2018 - 10/2016
2	Myotonic Dystrophy (Dystrophia Myotonica) 01/2018 - 01/2018
1	Takotsubo Cardiomyopathy 10/2023
1	Cardiotoxicity 10/2023
1	Cardiomyopathies (Cardiomyopathy) 10/2023
1	Hemophilia A (Haemophilia) 09/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2023
1	Liver Diseases (Liver Disease) 09/2023
1	Transthyretin-Related Hereditary Amyloidosis 09/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Injection Site Reaction 11/2022
1	Kidney Calculi (Kidney Stone) 11/2022
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Atherosclerosis 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Obesity 01/2022
1	Leukemia 11/2021
1	Ischemic Stroke 01/2021
1	Hypercholesterolemia 01/2021
1	Stroke (Strokes) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Carcinogenesis 12/2019
1	Kidney Diseases (Kidney Disease) 11/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Glioma (Gliomas) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Thalassemia 01/2018
1	Reticulocytosis 10/2016
1	Cystic Fibrosis (Mucoviscidosis) 04/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2013
1	Squamous Cell Carcinoma of Head and Neck 02/2013

Drug/Important Bio-Agent (IBA)

10	MicroRNAs (MicroRNA)IBA 10/2023 - 02/2015
9	Peptide Nucleic AcidsIBA 01/2023 - 02/2013
4	pHLIP proteinIBA 01/2022 - 12/2019
4	Peptides (Polypeptides)IBA 01/2020 - 02/2015
3	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2020
2	Small Interfering RNA (siRNA)IBA 09/2023 - 11/2022
2	AntagomirsIBA 11/2022 - 01/2021
2	OligonucleotidesIBA 01/2022 - 01/2021
2	Antisense OligonucleotidesIBA 01/2022 - 01/2022
2	Nucleic AcidsIBA 01/2020 - 01/2018
2	GlobinsIBA 01/2018 - 10/2016
2	Guanidine (Guanidine Nitrate)FDA Link 10/2013 - 02/2013
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Serine (L-Serine)FDA Link 10/2023
1	diethylene glycolIBA 10/2023
1	AldehydesIBA 10/2023
1	CatecholaminesIBA 10/2023
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 10/2023
1	Complement System Proteins (Complement)IBA 09/2023
1	Acute Hepatic PorphyriaIBA 09/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	OxalatesIBA 11/2022
1	nedosiranIBA 11/2022
1	lumasiranIBA 11/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	LipidsIBA 01/2022
1	casimersenIBA 01/2022
1	CollagenIBA 01/2022
1	AntigensIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	polyhistidineIBA 09/2021
1	ALN-PCSIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2019
1	Nucleic Acid ProbesIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013
1	LuciferasesIBA 10/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2013
1	CateninsIBA 10/2013
1	NucleotidesIBA 02/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2013
1	Cetuximab (Erbitux)FDA Link 02/2013
1	glutarylphenylalanine-4-nitroanilideIBA 02/2013
1	ErbB Receptors (EGF Receptor)IBA 02/2013

Therapy/Procedure

13	Therapeutics 01/2024 - 02/2015
2	Drug Therapy (Chemotherapy) 11/2022 - 01/2019
1	Precision Medicine 11/2021
1	Radiotherapy 01/2020
1	Intravenous Administration 10/2016